Bimatoprost (Sandoz Inc)


Welcome to the PulseAid listing for the Bimatoprost drug offered from Sandoz Inc. This Prostaglandin Analog [EPC],Prostaglandins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sandoz Inc
NON-PROPRIETARY NAME: Bimatoprost
SUBSTANCE NAME: BIMATOPROST
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Prostaglandin Analog [EPC],Prostaglandins [Chemical/Ingredient]
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-12-06
END MARKETING DATE: 0000-00-00


Bimatoprost HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBimatoprost from Sandoz Inc
LABELER NAME: Sandoz Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 0.3(mg/mL)
START MARKETING DATE: 2016-12-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0781-6206_56915d23-20c4-46bc-9832-cf56186bf006
PRODUCT NDC: 0781-6206
APPLICATION NUMBER: ANDA202719

Other BIMATOPROST Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allergan, Inc.LUMIGAN
LUPIN LIMITEDbimatoprost
Lupin Pharmaceuticals, Inc.bimatoprost
Physicians Total Care, Inc.LUMIGAN
Sandoz IncBimatoprost